Rigel Pharmaceuticals, Inc. (RIGL)
NASDAQ: RIGL · Real-Time Price · USD
38.70
+1.27 (3.39%)
Aug 4, 2026, 4:00 PM EDT - Market closed
Rigel Pharmaceuticals Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Operating Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | 321.91 | 367.02 | 17.49 | -25.09 | -58.57 | -17.91 |
Depreciation & Amortization | 2.65 | 2.42 | 2.23 | 1.24 | 1 | 1.16 |
Stock-Based Compensation | 16.41 | 12.71 | 12.39 | 8.81 | 12.39 | 9.49 |
Other Adjustments | -238.98 | -286.98 | -0.79 | -0.21 | 0.48 | 3.43 |
Change in Receivables | -16.13 | -10.15 | -11.07 | 9.77 | -24.85 | 0.5 |
Changes in Inventories | -2.52 | -5.64 | 0.76 | 1.17 | -2.38 | -4.88 |
Changes in Accounts Payable | -3.28 | 3.85 | -3.8 | -0.37 | 3.79 | 0.04 |
Changes in Accrued Expenses | 3.73 | 2.94 | 7.02 | -6.59 | -2.79 | 6.57 |
Changes in Unearned Revenue | -1.53 | 1.28 | 10.76 | 3.54 | 3 | 1.43 |
Changes in Other Operating Activities | -3.07 | -11.8 | -3.52 | 2 | -5.82 | 6.05 |
Operating Cash Flow | 79.39 | 75.66 | 31.47 | -5.74 | -73.76 | 5.88 |
Operating Cash Flow Growth | 20.60% | 140.40% | - | - | - | - |
Investing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Capital Expenditures | 0.01 | - | -0.04 | - | -0.45 | -0.63 |
Sale of Property, Plant & Equipment | - | - | 0.1 | 0.26 | 0.89 | - |
Purchases of Intangible Assets | -70.35 | - | -0.36 | -15 | - | - |
Purchases of Investments | -121.72 | -153.49 | -35.27 | -31.21 | -28.89 | -141.46 |
Proceeds from Sale of Investments | 62.07 | 61.13 | 39.7 | 41.65 | 101.23 | 62.05 |
Investing Cash Flow | -49.06 | -92.37 | 4.13 | -4.3 | 72.78 | -80.04 |
Financing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Long-Term Debt Issued | - | - | - | 19.95 | 19.54 | - |
Long-Term Debt Repaid | -62.75 | -7.5 | - | - | - | - |
Net Long-Term Debt Issued (Repaid) | -62.75 | -7.5 | - | 19.95 | 19.54 | - |
Issuance of Common Stock | 9.38 | 8.1 | 1.96 | 1.05 | 2.12 | 4.78 |
Repurchase of Common Stock | -4.25 | - | - | - | - | - |
Net Common Stock Issued (Repurchased) | 5.13 | 8.1 | 1.96 | 1.05 | 2.12 | 4.78 |
Other Financing Activities | - | - | -13.61 | -2.63 | -15.12 | 57.9 |
Financing Cash Flow | -22.92 | 0.6 | -11.64 | 18.37 | 6.55 | 62.68 |
Net Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Cash Flow | 7.41 | -16.11 | 23.96 | 8.33 | 5.57 | -11.48 |
Free Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | 79.4 | 75.66 | 31.44 | -5.74 | -74.21 | 5.25 |
Free Cash Flow Growth | 20.62% | 140.67% | - | - | - | - |
FCF Margin | 28.69% | 25.71% | 17.53% | -4.91% | -61.72% | 3.52% |
Free Cash Flow Per Share | 4.06 | 4.02 | 1.78 | -0.33 | -4.35 | 0.31 |
Levered Free Cash Flow | 255.15 | 352.58 | 30.9 | -4.16 | -42.68 | -8.16 |
Unlevered Free Cash Flow | 323.44 | 371.04 | 36.44 | -19.51 | -59.2 | -3.18 |